Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Posts by Peter W. PENG

Home » Archives for Peter W. PENG
About Peter W. PENG
CSCO 2025 │ Professor Lili Mao: Updates to Perioperative Therapy in the 2025 CSCO Melanoma Guidelines

CSCO 2025 │ Professor Lili Mao: Updates to Perioperative Therapy in the 2025 CSCO Melanoma Guidelines

Posted by By Peter W. PENG 2025.09.29
Editor’s Note: Unlike Western countries where cutaneous melanoma predominates, acral and mucosal melanomas are more common in China. With the rapid development of immunotherapy and targeted therapy, perioperative treatment strategies…
Read More
“Those Who Fail to See the Whole Cannot Govern the Parts” — Professor Qiang Liu Shares New Perspectives on Neoadjuvant Therapy for Breast Cancer

“Those Who Fail to See the Whole Cannot Govern the Parts” — Professor Qiang Liu Shares New Perspectives on Neoadjuvant Therapy for Breast Cancer

Posted by By Peter W. PENG 2025.09.29
Editor’s Note: In breast cancer treatment, the use of neoadjuvant therapy has become increasingly widespread, and its concepts continue to evolve—from traditional treatment models to today’s focus on individualized care…
Read More

Transforming mHSPC Management: A New Era of Combination Strategies

Posted by By Peter W. PENG 2025.09.28
Read More
 CSCO 2025 | Professor Ma Jun: 120 Years of Chinese Hematology Establishing a Global Benchmark – CSCO Annual Meeting to Decode Innovative Therapies and Cutting-Edge Breakthroughs 

 CSCO 2025 | Professor Ma Jun: 120 Years of Chinese Hematology Establishing a Global Benchmark – CSCO Annual Meeting to Decode Innovative Therapies and Cutting-Edge Breakthroughs 

Posted by By Peter W. PENG 2025.09.27
The 28th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) will be held in Jinan, Shandong, from September 10–14, 2025. This year’s meeting, themed “Standardized Diagnosis and Treatment,…
Read More

Prof. Zhuowei Liu: Innovations and Research in Urothelial Carcinoma Practice

Posted by By Peter W. PENG 2025.09.26
Read More
CSCO Experts’ Voice | Professor Jianming Guo: Outlook on the Development of China’s Prostate Cancer MDT Model and the Future of AI Applications

CSCO Experts’ Voice | Professor Jianming Guo: Outlook on the Development of China’s Prostate Cancer MDT Model and the Future of AI Applications

Posted by By Peter W. PENG 2025.09.25
Editor’s Note: This September, the 28th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO 2025), one of China’s most prestigious oncology conferences, was successfully held in Jinan. During…
Read More

CSCO Global Dialogue | Insights from Professors Zefei Jiang & Shigehira Saji

Posted by By Peter W. PENG 2025.09.21
Read More

UTUC Systemic Therapy: Challenges, Breakthroughs, and Future Directions – Dr. Chunguang Ma, Fudan University Shanghai Cancer Center

Posted by By Peter W. PENG 2025.09.19
Read More
2025 COMB丨Professor Fei Ma: New Perspectives in Breast Cancer Immunotherapy—Mechanistic Insights, Adverse Event Management, and Precision Pathways

2025 COMB丨Professor Fei Ma: New Perspectives in Breast Cancer Immunotherapy—Mechanistic Insights, Adverse Event Management, and Precision Pathways

Posted by By Peter W. PENG 2025.09.19
Editor’s Note: Immunotherapy has become an important treatment modality in breast cancer, achieving breakthroughs by modulating the immune system to mount anti-tumor responses. At the 8th Conference on Oncology Precision…
Read More
Professor Bing Han: Treatment Strategies for Aplastic Anemia in the TPO-RA Era

Professor Bing Han: Treatment Strategies for Aplastic Anemia in the TPO-RA Era

Posted by By Peter W. PENG 2025.09.18
Editor’s Note: The 13th Ludaopei Hematology Academic Conference, jointly organized by the Beijing Health Promotion Association and the Hongmian Tumor and Rare Disease Public Welfare Foundation, and hosted by the…
Read More

Posts pagination

1 2 3 … 20 Next page
Recent Posts
  • ISEH 2025 | Professor Tao Cheng: Revitalizing Sino-Japanese Hematology Exchange and Exploring the Frontiers of Cell and Gene Therapy
  • CSCO 2025 │ Professor Lili Mao: Updates to Perioperative Therapy in the 2025 CSCO Melanoma Guidelines
  • Professor Haibo Wang: Advancing Comprehensive Breast Cancer Care through Innovation and Multidisciplinary Collaboration
  • “Those Who Fail to See the Whole Cannot Govern the Parts” — Professor Qiang Liu Shares New Perspectives on Neoadjuvant Therapy for Breast Cancer
  • CSCO Journey │ Professor Man Li: CSCO Member No. 168, Witness to China’s Leap Forward in Clinical Oncology
Recent Comments
    Archives
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top